AKB-6548
AKB-6548-CI-0011
Phase 2 small_molecule completed
Quick answer
AKB-6548 for Anemia is a Phase 2 program (small_molecule) at Akebia Therapeutics with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Anemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed